{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T04:13:32Z","timestamp":1746072812425,"version":"3.40.4"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,29]]},"DOI":"10.7759\/cureus.83228","type":"journal-article","created":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T06:01:26Z","timestamp":1745992886000},"source":"Crossref","is-referenced-by-count":0,"title":["Neurological Manifestations of Influenza Vaccination: A Narrative Review"],"prefix":"10.7759","author":[{"given":"Hayfa","family":"AlAli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dima","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wdad","family":"AlAttar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moza","family":"Almualla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahd","family":"Ghanim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fawaghi","family":"Robari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Influenza (seasonal). (2023). Accessed. April 19, 2024: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/influenza-(seasonal)."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)61051-9","article-title":"Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis","volume":"378","author":"Nair H","year":"2011","unstructured":"Nair H, Brooks WA, Katz M, et al.. Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis. Lancet. 2011, 378:1917-30. 10.1016\/S0140-6736(11)61051-9","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.rr7101a1","article-title":"Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices - United States, 2022-23 influenza season","volume":"71","author":"Grohskopf LA","year":"2022","unstructured":"Grohskopf LA, Blanton LH, Ferdinands JM, et al.. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices - United States, 2022-23 influenza season. MMWR Recomm Rep. 2022, 71:1-28. 10.15585\/mmwr.rr7101a1","journal-title":"MMWR Recomm Rep"},{"key":"ref4","article-title":"History and evolution of influenza control through vaccination: from the first monovalent vaccine to universal vaccines","volume":"57","author":"Barberis I","year":"2016","unstructured":"Barberis I, Myles P, Ault S, Bragazzi N, & Martini M. History and evolution of influenza control through vaccination: from the first monovalent vaccine to universal vaccines. J Prev Med Hyg. 2016, 57:E115-E120.","journal-title":"J Prev Med Hyg"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/nrd4529","article-title":"Advances in the development of influenza virus vaccines","volume":"14","author":"Krammer F","year":"2015","unstructured":"Krammer F, Palese P. Advances in the development of influenza virus vaccines. Nat Rev Drug Discov. 2015, 14:167-82. 10.1038\/nrd4529","journal-title":"Nat Rev Drug Discov"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/v13060971","article-title":"Selecting and using the appropriate influenza vaccine for each individual","volume":"13","author":"Sekiya T","year":"2021","unstructured":"Sekiya T, Ohno M, Nomura N, et al.. Selecting and using the appropriate influenza vaccine for each individual. Viruses. 2021, 13:971. 10.3390\/v13060971","journal-title":"Viruses"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiab269","article-title":"Influenza vaccines: successes and continuing challenges","volume":"224","author":"Becker T","year":"2021","unstructured":"Becker T, Elbahesh H, Reperant LA, Rimmelzwaan GF, Osterhaus AD. Influenza vaccines: successes and continuing challenges. J Infect Dis. 2021, 224:S405-19. 10.1093\/infdis\/jiab269","journal-title":"J Infect Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1159\/000052820","article-title":"Side effects of influenza vaccination in healthy older people: a randomised single-blind placebo-controlled trial","volume":"47","author":"Allsup SJ","year":"2001","unstructured":"Allsup SJ, Gosney M, Regan M, Haycox A, Fear S, Johnstone FC. Side effects of influenza vaccination in healthy older people: a randomised single-blind placebo-controlled trial. Gerontology. 2001, 47:311-4. 10.1159\/000052820","journal-title":"Gerontology"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/01.inf.0000116292.46143.d6","article-title":"Safety and efficacy of trivalent inactivated influenza vaccine in young children: a summary for the new era of routine vaccination","volume":"23","author":"Zangwill KM","year":"2004","unstructured":"Zangwill KM, Belshe RB. Safety and efficacy of trivalent inactivated influenza vaccine in young children: a summary for the new era of routine vaccination. Pediatr Infect Dis J. 2004, 23:189-97. 10.1097\/01.inf.0000116292.46143.d6","journal-title":"Pediatr Infect Dis J"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.pedneo.2021.05.002","article-title":"Clinical features and risk factors for severe influenza in children: a study from multiple hospitals in Shanghai","volume":"62","author":"Shi Y","year":"2021","unstructured":"Shi Y, Chen W, Zeng M, et al.. Clinical features and risk factors for severe influenza in children: a study from multiple hospitals in Shanghai. Pediatr Neonatol. 2021, 62:428-36. 10.1016\/j.pedneo.2021.05.002","journal-title":"Pediatr Neonatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0033723","article-title":"Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in Finland","volume":"7","author":"Partinen M","year":"2012","unstructured":"Partinen M, Saarenp\u00e4\u00e4-Heikkil\u00e4 O, Ilveskoski I, et al.. Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in Finland. PLoS One. 2012, 7:e33723. 10.1371\/journal.pone.0033723","journal-title":"PLoS One"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000207337","article-title":"Neurologic complications with vaccines: what we know, what we don't, and what we should do","volume":"101","author":"Nath A","year":"2023","unstructured":"Nath A. Neurologic complications with vaccines: what we know, what we don't, and what we should do. Neurology. 2023, 101:621-6. 10.1212\/WNL.0000000000207337","journal-title":"Neurology"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kws196","article-title":"Guillain-Barre syndrome during the 2009-2010 H1N1 influenza vaccination campaign: population-based surveillance among 45 million Americans","volume":"175","author":"Wise ME","year":"2012","unstructured":"Wise ME, Viray M, Sejvar JJ, et al.. Guillain-Barre syndrome during the 2009-2010 H1N1 influenza vaccination campaign: population-based surveillance among 45 million Americans. Am J Epidemiol. 2012, 175:1110-9. 10.1093\/aje\/kws196","journal-title":"Am J Epidemiol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2016.03.048","article-title":"Post-licensure surveillance of quadrivalent inactivated influenza (IIV4) vaccine in the United States, Vaccine Adverse Event Reporting System (VAERS), July 1, 2013-May 31, 2015","volume":"34","author":"Haber P","year":"2016","unstructured":"Haber P, Moro PL, Lewis P, Woo EJ, Jankosky C, Cano M. Post-licensure surveillance of quadrivalent inactivated influenza (IIV4) vaccine in the United States, Vaccine Adverse Event Reporting System (VAERS), July 1, 2013-May 31, 2015. Vaccine. 2016, 34:2507-12. 10.1016\/j.vaccine.2016.03.048","journal-title":"Vaccine"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2008.08.033","article-title":"Guillain-Barr\u00e9 syndrome: an update","volume":"16","author":"Vucic S","year":"2009","unstructured":"Vucic S, Kiernan MC, Cornblath DR. Guillain-Barr\u00e9 syndrome: an update. J Clin Neurosci. 2009, 16:733-41. 10.1016\/j.jocn.2008.08.033","journal-title":"J Clin Neurosci"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a112795","article-title":"Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976--1977","volume":"110","author":"Schonberger LB","year":"1979","unstructured":"Schonberger LB, Bregman DJ, Sullivan-Bolyai JZ, et al.. Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976--1977. Am J Epidemiol. 1979, 110:105-23. 10.1093\/oxfordjournals.aje.a112795","journal-title":"Am J Epidemiol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/ene.15516","article-title":"Guillain-Barr\u00e9 syndrome following influenza vaccination: a 15-year nationwide population-based case-control study","volume":"29","author":"Levison LS","year":"2022","unstructured":"Levison LS, Thomsen RW, Andersen H. Guillain-Barr\u00e9 syndrome following influenza vaccination: a 15-year nationwide population-based case-control study. Eur J Neurol. 2022, 29:3389-94. 10.1111\/ene.15516","journal-title":"Eur J Neurol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiaa543","article-title":"Guillain-Barr\u00e9 syndrome after high-dose influenza vaccine administration in the United States, 2018-2019 season","volume":"223","author":"Perez-Vilar S","year":"2021","unstructured":"Perez-Vilar S, Hu M, Weintraub E, et al.. Guillain-Barr\u00e9 syndrome after high-dose influenza vaccine administration in the United States, 2018-2019 season. J Infect Dis. 2021, 223:416-25. 10.1093\/infdis\/jiaa543","journal-title":"J Infect Dis"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.10208","article-title":"Antigenic variability: a potential factor in assessing the relationship between Guillain-Barr\u00e9 syndrome and influenza vaccine\u2014Up-To-Date literature review","volume":"12","author":"Soni R","year":"2020","unstructured":"Soni R, Heindl SE, Wiltshire DA, Vahora IS, Khan S. Antigenic variability: a potential factor in assessing the relationship between Guillain-Barr\u00e9 syndrome and influenza vaccine\u2014Up-To-Date literature review. Cureus. 2020, 12:e10208. 10.7759\/cureus.10208","journal-title":"Cureus"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1P078","article-title":"Guillain-Barr\u00e9 syndrome following H1N1 immunization in a pediatric patient","volume":"44","author":"Tremblay ME","year":"2010","unstructured":"Tremblay ME, Closon A, D'Anjou G, Bussi\u00e8res JF. Guillain-Barr\u00e9 syndrome following H1N1 immunization in a pediatric patient. Ann Pharmacother. 2010, 44:1330-3. 10.1345\/aph.1P078","journal-title":"Ann Pharmacother"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1177\/2329048X221115476","article-title":"Acute bulbar palsy-plus variant of Guillain-Barr\u00e9 syndrome in a 3-year-old girl","volume":"9","author":"Dukkipati SS","year":"2022","unstructured":"Dukkipati SS, Zhou DJ, Powers AM, Piccione EA, Koh S. Acute bulbar palsy-plus variant of Guillain-Barr\u00e9 syndrome in a 3-year-old girl. Child Neurol Open. 2022, 9:2329048X221115476. 10.1177\/2329048X221115476","journal-title":"Child Neurol Open"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1085-9489.2005.0010202.x","article-title":"The immunobiology of Guillain-Barr\u00e9 syndromes","volume":"10","author":"Willison HJ","year":"2005","unstructured":"Willison HJ. The immunobiology of Guillain-Barr\u00e9 syndromes. J Peripher Nerv Syst. 2005, 10:94-112. 10.1111\/j.1085-9489.2005.0010202.x","journal-title":"J Peripher Nerv Syst"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.2478\/jtim-2019-0028","article-title":"Influenza vaccination and Guillain-Barr\u00e9 syndrome: reality or fear","volume":"7","author":"Babazadeh A","year":"2019","unstructured":"Babazadeh A, Mohseni Afshar Z, Javanian M, et al.. Influenza vaccination and Guillain-Barr\u00e9 syndrome: reality or fear. J Transl Int Med. 2019, 7:137-42. 10.2478\/jtim-2019-0028","journal-title":"J Transl Int Med"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1111\/j.1750-2659.2011.00294.x","article-title":"No evidence of a link between influenza vaccines and Guillain-Barre syndrome-associated antiganglioside antibodies","volume":"6","author":"Wang DJ","year":"2012","unstructured":"Wang DJ, Boltz DA, McElhaney J, McCullers JA, Webby RJ, Webster RG. No evidence of a link between influenza vaccines and Guillain-Barre syndrome-associated antiganglioside antibodies. Influenza Other Respir Viruses. 2012, 6:159-66. 10.1111\/j.1750-2659.2011.00294.x","journal-title":"Influenza Other Respir Viruses"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa030595","article-title":"Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland","volume":"350","author":"Mutsch M","year":"2004","unstructured":"Mutsch M, Zhou W, Rhodes P, et al.. Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland. N Engl J Med. 2004, 350:896-903. 10.1056\/NEJMoa030595","journal-title":"N Engl J Med"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0175539","article-title":"Bell's palsy and influenza(H1N1)pdm09 containing vaccines: a self-controlled case series","volume":"12","author":"Wijnans L","year":"2017","unstructured":"Wijnans L, Dodd CN, Weibel D, Sturkenboom M. Bell's palsy and influenza(H1N1)pdm09 containing vaccines: a self-controlled case series. PLoS One. 2017, 12:e0175539. 10.1371\/journal.pone.0175539","journal-title":"PLoS One"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kws011","article-title":"Immunization and Bell's palsy in children: a case-centered analysis","volume":"175","author":"Rowhani-Rahbar A","year":"2012","unstructured":"Rowhani-Rahbar A, Klein NP, Lewis N, et al.. Immunization and Bell's palsy in children: a case-centered analysis. Am J Epidemiol. 2012, 175:878-85. 10.1093\/aje\/kws011","journal-title":"Am J Epidemiol"},{"key":"ref28","unstructured":"Bell\u2019s Palsy following intranasal vaccination. (2022). Accessed. June 07, 2024: https:\/\/www.who.int\/groups\/global-advisory-committee-on-vaccine-safety\/topics\/bell-s-palsy-following-intranasal-vacci...."},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1093\/fampra\/cmab068","article-title":"Facial paralysis and vaccinations: a vaccine adverse event reporting system review","volume":"39","author":"Ahsanuddin S","year":"2022","unstructured":"Ahsanuddin S, Nasser W, Roy SC, Povolotskiy R, Paskhover B. Facial paralysis and vaccinations: a vaccine adverse event reporting system review. Fam Pract. 2022, 39:80-4. 10.1093\/fampra\/cmab068","journal-title":"Fam Pract"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoto.2023.1392","article-title":"Association of influenza vaccination with risk of Bell palsy among older adults in Taiwan","volume":"149","author":"Hu C","year":"2023","unstructured":"Hu C, Wei KC, Wang WH, Chang YC, Huang YT. Association of influenza vaccination with risk of Bell palsy among older adults in Taiwan. JAMA Otolaryngol Head Neck Surg. 2023, 149:726-34. 10.1001\/jamaoto.2023.1392","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1177\/00099228231158366","article-title":"Incomplete Bell\u2019s palsy following influenza vaccination in a 7-month-old","volume":"62","author":"Silverman E","year":"2023","unstructured":"Silverman E, Matsumoto C, Wang HC, Ma L. Incomplete Bell\u2019s palsy following influenza vaccination in a 7-month-old. Clin Pediatr (Phila). 2023, 62:1318-22. 10.1177\/00099228231158366","journal-title":"Clin Pediatr (Phila)"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2012.05.008","article-title":"Bell's palsy and autoimmunity","volume":"12","author":"Greco A","year":"2012","unstructured":"Greco A, Gallo A, Fusconi M, Marinelli C, Macri GF, de Vincentiis M. Bell's palsy and autoimmunity. Autoimmun Rev. 2012, 12:323-8. 10.1016\/j.autrev.2012.05.008","journal-title":"Autoimmun Rev"},{"key":"ref33","article-title":"Febrile Seizure","author":"Xixis KL","year":"2025","unstructured":"Xixis KL, Samanta D, Smith T, Keenaghan M. Febrile Seizure. StatPearls [Internet], StatPearls Publishing, Treasure Island, FL; 2025."},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.12.042","article-title":"Febrile seizures after 2010-2011 influenza vaccine in young children, United States: a vaccine safety signal from the vaccine adverse event reporting system","volume":"30","author":"Leroy Z","year":"2012","unstructured":"Leroy Z, Broder K, Menschik D, Shimabukuro T, Martin D. Febrile seizures after 2010-2011 influenza vaccine in young children, United States: a vaccine safety signal from the vaccine adverse event reporting system. Vaccine. 2012, 30:2020-3. 10.1016\/j.vaccine.2011.12.042","journal-title":"Vaccine"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.01.027","article-title":"Signal identification and evaluation for risk of febrile seizures in children following trivalent inactivated influenza vaccine in the Vaccine Safety Datalink Project, 2010-2011","volume":"30","author":"Tse A","year":"2012","unstructured":"Tse A, Tseng HF, Greene SK, Vellozzi C, Lee GM. Signal identification and evaluation for risk of febrile seizures in children following trivalent inactivated influenza vaccine in the Vaccine Safety Datalink Project, 2010-2011. Vaccine. 2012, 30:2024-31. 10.1016\/j.vaccine.2012.01.027","journal-title":"Vaccine"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2013.4469","article-title":"Risk of fever after pediatric trivalent inactivated influenza vaccine and 13-valent pneumococcal conjugate vaccine","volume":"168","author":"Stockwell MS","year":"2014","unstructured":"Stockwell MS, Broder K, LaRussa P, et al.. Risk of fever after pediatric trivalent inactivated influenza vaccine and 13-valent pneumococcal conjugate vaccine. JAMA Pediatr. 2014, 168:211-9. 10.1001\/jamapediatrics.2013.4469","journal-title":"JAMA Pediatr"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.es2015.20.24.21159","article-title":"Systematic review of fever, febrile convulsions and serious adverse events following administration of inactivated trivalent influenza vaccines in children","volume":"20","author":"Li-Kim-Moy J","year":"2015","unstructured":"Li-Kim-Moy J, Yin JK, Rashid H, et al.. Systematic review of fever, febrile convulsions and serious adverse events following administration of inactivated trivalent influenza vaccines in children. Euro Surveill. 2015, 20:21159. 10.2807\/1560-7917.es2015.20.24.21159","journal-title":"Euro Surveill"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-015-1263-7","article-title":"Febrile seizures after 2009 influenza A (H1N1) vaccination and infection: a nationwide registry-based study","volume":"15","author":"Bakken IJ","year":"2015","unstructured":"Bakken IJ, Aaberg KM, Ghaderi S, Gunnes N, Trogstad L, Magnus P, H\u00e5berg SE. Febrile seizures after 2009 influenza A (H1N1) vaccination and infection: a nationwide registry-based study. BMC Infect Dis. 2015, 15:506. 10.1186\/s12879-015-1263-7","journal-title":"BMC Infect Dis"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.2807\/ese.16.26.19904-en","article-title":"Swedish Medical Products Agency publishes report from a case inventory study on Pandemrix vaccination and development of narcolepsy with cataplexy","volume":"16","author":"Eurosurveillance editorial team","year":"2011","unstructured":"Eurosurveillance editorial team. Swedish Medical Products Agency publishes report from a case inventory study on Pandemrix vaccination and development of narcolepsy with cataplexy. Euro Surveill. 2011, 16:19904. 10.2807\/ese.16.26.19904-en","journal-title":"Euro Surveill"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f794","article-title":"Risk of narcolepsy in children and young people receiving AS03 adjuvanted pandemic A\/H1N1 2009 influenza vaccine: retrospective analysis","volume":"346","author":"Miller E","year":"2013","unstructured":"Miller E, Andrews N, Stellitano L, Stowe J, Winstone AM, Shneerson J, Verity C. Risk of narcolepsy in children and young people receiving AS03 adjuvanted pandemic A\/H1N1 2009 influenza vaccine: retrospective analysis. BMJ. 2013, 346:f794. 10.1136\/bmj.f794","journal-title":"BMJ"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003225","article-title":"Reassessment of the risk of narcolepsy in children in England 8 years after receipt of the AS03-adjuvanted H1N1 pandemic vaccine: a case-coverage study","volume":"17","author":"Stowe J","year":"2020","unstructured":"Stowe J, Andrews N, Gringras P, Quinnell T, Zaiwalla Z, Shneerson J, Miller E. Reassessment of the risk of narcolepsy in children in England 8 years after receipt of the AS03-adjuvanted H1N1 pandemic vaccine: a case-coverage study. PLoS Med. 2020, 17:e1003225. 10.1371\/journal.pmed.1003225","journal-title":"PLoS Med"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1111\/dmcn.12522","article-title":"Clinical features of narcolepsy in children vaccinated with AS03 adjuvanted pandemic A\/H1N1 2009 influenza vaccine in England","volume":"56","author":"Winstone AM","year":"2014","unstructured":"Winstone AM, Stellitano L, Verity C, Andrews N, Miller E, Stowe J, Shneerson J. Clinical features of narcolepsy in children vaccinated with AS03 adjuvanted pandemic A\/H1N1 2009 influenza vaccine in England. Dev Med Child Neurol. 2014, 56:1117-23. 10.1111\/dmcn.12522","journal-title":"Dev Med Child Neurol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/j.smrv.2017.06.006","article-title":"Incidence of narcolepsy after H1N1 influenza and vaccinations: systematic review and meta-analysis","volume":"38","author":"Sarkanen TO","year":"2018","unstructured":"Sarkanen TO, Alakuijala AP, Dauvilliers YA, Partinen MM. Incidence of narcolepsy after H1N1 influenza and vaccinations: systematic review and meta-analysis. Sleep Med Rev. 2018, 38:177-86. 10.1016\/j.smrv.2017.06.006","journal-title":"Sleep Med Rev"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.08.008","article-title":"Narcolepsy and adjuvanted pandemic influenza A (H1N1) 2009 vaccines - multi-country assessment","volume":"36","author":"Weibel D","year":"2018","unstructured":"Weibel D, Sturkenboom M, Black S, et al.. Narcolepsy and adjuvanted pandemic influenza A (H1N1) 2009 vaccines - multi-country assessment. Vaccine. 2018, 36:6202-11. 10.1016\/j.vaccine.2018.08.008","journal-title":"Vaccine"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000000987","article-title":"Narcolepsy and influenza A(H1N1) pandemic 2009 vaccination in the United States","volume":"83","author":"Duffy J","year":"2014","unstructured":"Duffy J, Weintraub E, Vellozzi C, DeStefano F. Narcolepsy and influenza A(H1N1) pandemic 2009 vaccination in the United States. Neurology. 2014, 83:1823-30. 10.1212\/WNL.0000000000000987","journal-title":"Neurology"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtauto.2020.100055","article-title":"No evidence of autoimmunity to human OX(1) or OX(2) orexin receptors in Pandemrix-vaccinated narcoleptic children","volume":"3","author":"Mel\u00e9n K","year":"2020","unstructured":"Mel\u00e9n K, Jalkanen P, Kukkonen JP, et al.. No evidence of autoimmunity to human OX(1) or OX(2) orexin receptors in Pandemrix-vaccinated narcoleptic children. J Transl Autoimmun. 2020, 3:100055. 10.1016\/j.jtauto.2020.100055","journal-title":"J Transl Autoimmun"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0129555","article-title":"Neuronal Antibodies in children with or without narcolepsy following H1N1-AS03 vaccination","volume":"10","author":"Thebault S","year":"2015","unstructured":"Thebault S, Waters P, Snape MD, et al.. Neuronal Antibodies in children with or without narcolepsy following H1N1-AS03 vaccination. PLoS One. 2015, 10:e0129555. 10.1371\/journal.pone.0129555","journal-title":"PLoS One"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22637-8","article-title":"Enhanced influenza A H1N1 T cell epitope recognition and cross-reactivity to protein-O-mannosyltransferase 1 in Pandemrix-associated narcolepsy type 1","volume":"12","author":"Vuorela A","year":"2021","unstructured":"Vuorela A, Freitag TL, Leskinen K, et al.. Enhanced influenza A H1N1 T cell epitope recognition and cross-reactivity to protein-O-mannosyltransferase 1 in Pandemrix-associated narcolepsy type 1. Nat Commun. 2021, 12:2283. 10.1038\/s41467-021-22637-8","journal-title":"Nat Commun"},{"key":"ref49","unstructured":"New data on narcolepsy following the 2009 pandemic influenza vaccine. (2017). Accessed. June 11, 2024: https:\/\/www.who.int\/groups\/global-advisory-committee-on-vaccine-safety\/topics\/influenza-vaccines\/h1n1-vaccines."},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.08.111","article-title":"Brainstem encephalitis following influenza vaccination: favorable response to steroid treatment","volume":"27","author":"T\u00fcrko\u011flu R","year":"2009","unstructured":"T\u00fcrko\u011flu R, T\u00fcz\u00fcn E. Brainstem encephalitis following influenza vaccination: favorable response to steroid treatment. Vaccine. 2009, 27:7253-6. 10.1016\/j.vaccine.2009.08.111","journal-title":"Vaccine"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2014.06.003","article-title":"Encephalitis related to a H1N1 vaccination: case report and review of the literature","volume":"124","author":"Ussel IV","year":"2014","unstructured":"Ussel IV, Boer W, Parizel P, Cras P, Jorens PG. Encephalitis related to a H1N1 vaccination: case report and review of the literature. Clin Neurol Neurosurg. 2014, 124:8-15. 10.1016\/j.clineuro.2014.06.003","journal-title":"Clin Neurol Neurosurg"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.3390\/neurosci6010001","article-title":"Pediatric acute disseminated encephalomyelitis triggered by concurrent administration of seasonal and H1N1 influenza vaccines: a case report and review","volume":"6","author":"Imataka G","year":"2024","unstructured":"Imataka G, Shiraishi H, Yoshihara S. Pediatric acute disseminated encephalomyelitis triggered by concurrent administration of seasonal and H1N1 influenza vaccines: a case report and review. NeuroSci. 2024, 6:1. 10.3390\/neurosci6010001","journal-title":"NeuroSci"},{"key":"ref53","article-title":"Encephalitis after vaccination in United States. A report from the CDC\/FDA vaccine adverse event reporting system [1990-2010]","volume":"78","author":"Al Qudah Z","year":"2012","unstructured":"Al Qudah Z, Abukwaik W, Patel H, Souayah N. Encephalitis after vaccination in United States. A report from the CDC\/FDA vaccine adverse event reporting system [1990-2010]. Neurology. 2012, 78:P03.151.","journal-title":"Neurology"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1002\/pds.3575","article-title":"Absence of associations between influenza vaccines and increased risks of seizures, Guillain-Barr\u00e9 syndrome, encephalitis, or anaphylaxis in the 2012-2013 season","volume":"23","author":"Kawai AT","year":"2014","unstructured":"Kawai AT, Li L, Kulldorff M, et al.. Absence of associations between influenza vaccines and increased risks of seizures, Guillain-Barr\u00e9 syndrome, encephalitis, or anaphylaxis in the 2012-2013 season. Pharmacoepidemiol Drug Saf. 2014, 23:548-53. 10.1002\/pds.3575","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.3345\/kjp.2011.54.10.422","article-title":"An adverse event following 2009 H1N1 influenza vaccination: a case of acute disseminated encephalomyelitis","volume":"54","author":"Lee ST","year":"2011","unstructured":"Lee ST, Choe YJ, Moon WJ, Choi JW, Lee R. An adverse event following 2009 H1N1 influenza vaccination: a case of acute disseminated encephalomyelitis. Korean J Pediatr. 2011, 54:422-4. 10.3345\/kjp.2011.54.10.422","journal-title":"Korean J Pediatr"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.05.063","article-title":"Vaccines and the risk of acute disseminated encephalomyelitis","volume":"36","author":"Chen Y","year":"2018","unstructured":"Chen Y, Ma F, Xu Y, Chu X, Zhang J. Vaccines and the risk of acute disseminated encephalomyelitis. Vaccine. 2018, 36:3733-9. 10.1016\/j.vaccine.2018.05.063","journal-title":"Vaccine"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1097\/MS9.0000000000001656","article-title":"Neurological complications of influenza vaccination: navigating the spectrum with a focus on acute disseminated encephalomyelitis (ADEM)","volume":"86","author":"Mashkoor Y","year":"2024","unstructured":"Mashkoor Y, Nadeem A, Fatima T, et al.. Neurological complications of influenza vaccination: navigating the spectrum with a focus on acute disseminated encephalomyelitis (ADEM). Ann Med Surg (Lond). 2024, 86:1029-41. 10.1097\/MS9.0000000000001656","journal-title":"Ann Med Surg (Lond)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/352387-neurological-manifestations-of-influenza-vaccination-a-narrative-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T06:01:29Z","timestamp":1745992889000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/352387-neurological-manifestations-of-influenza-vaccination-a-narrative-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,29]]},"references-count":57,"URL":"https:\/\/doi.org\/10.7759\/cureus.83228","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4,29]]}}}